Navigation Links
E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality
Date:7/7/2008

LEXINGTON, Ky., July 7 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM) the nation's only proven Real-Time Prescription Monitoring System announced it's support today of a proposed rule that would allow for the electronic prescribing of controlled substances.

June 27th, the Drug Enforcement Administration proposed regulations that would allow physicians to electronically prescribe controlled substances. Current rules bar e-prescriptions for controlled substances, classified as medications that have the potential for abuse or addiction. Controlled substances account for between 10% and 13% of all U.S. prescriptions. The DEA hopes to reduce prescription forgery by creating a "closed system of controls on controlled-substances dispensing." In a separate initiative the House recently approved a bill (HR 6331) that would provide an incentive to physicians to use e-prescribing that would sharply increase its adoption.

According to Jim Renfro, President of VHGI, "Both of these recent events are very exciting for Veriscrip because they are key factors in facilitating the use of e-prescribing in real-time Prescription Drug Monitoring. From the beginning our company has stressed the importance of tracking controlled substances from their inception electronically." Renfro goes on further to say, "I am confident that once these rules are put into effect, you will begin to see more local and state governments moving more aggressively to curtail the misuse and major abuse of prescription drugs in a real time manner. I think we have positioned Veriscrip to be a leader in this effort and to take full advantage of the potential new business, which will result from this rule change."

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors, including, but not limited to assumptions, beliefs and opinions relating to the business and growth strategy of VirtualHealth Technologies, Inc. and its wholly owned subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, LLC, Medical Office Software, Inc. and implementation thereof, based upon the Company's interpretation and analysis of financial and market conditions, the decisions of businesses with whom the Company is either engaged in business with or negotiating, healthcare industry trends and management's ability to successfully finance, develop, market, sell and implement its e-commerce and internet solutions, clinical and financial e-transaction services and software applications to physicians, pharmacies, governmental agencies, laboratories, insurance companies, HMOs, and payers. These factors and other risk factors are more fully discussed in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any intent or obligation to update any forward-looking statements.

Contact: Shareholder Relations

VirtualHealth Technologies, Inc.

325 West Main Street, Suite 240

Lexington, KY 40507

(859) 455-9255

Email: Shareholder.Relations@virtualhealthtechnologies.com

Website: http://www.virtualhealthtechnologies.com


'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
2. L.A. Care Offers ZixCorp e-Prescribing Services Through Health I.T. Incentive Program
3. PCMAs New Ad Campaign: E-Prescribing is Ready Now
4. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
5. CMS Releases Final E-Prescribing Standards in Medicare
6. Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing
7. PCMA Applauds Secretary Leavitts Support for Requiring E-Prescribing in Medicare
8. PCMA: 2008 Health Debate Highlights Workable Solutions Like E-Prescribing
9. PCMA 2008 Agenda: Support E-Prescribing, Biogenerics; Oppose Bills that Increase Costs
10. One Thing Washington Can Agree On: Time for E-Prescribing in Medicare
11. PCMA Supports Bipartisan Legislation Calling for E-Prescribing Requirement in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 According to ... Type (Standard Pen Needles, Safety Pen Needles), Needle Length ... Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Trends ... report studies the market for the forecast period of ... USD 2.81 Billion by 2021 from USD 1.65 Billion ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Global Market - Forecast to 2022" report to their ... treatment method for the patients with kidney failure, it replaces ... fluid from the patient,s blood and thus the treatment helps ... and chloride in balance. Increasing number of ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
Breaking Medicine Technology: